

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.24930037 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23768692 |
| 3 | response to peptidoglycan (GO:0032494) | 5.19531145 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 5.14563300 |
| 5 | type I interferon signaling pathway (GO:0060337) | 4.93694947 |
| 6 | cellular response to type I interferon (GO:0071357) | 4.93694947 |
| 7 | response to type I interferon (GO:0034340) | 4.88198274 |
| 8 | regulation of interferon-alpha production (GO:0032647) | 4.85650689 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.79448924 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.79448924 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.79448924 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.79448924 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.79448924 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.79448924 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.74441207 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.62244226 |
| 17 | cellular response to exogenous dsRNA (GO:0071360) | 4.51598610 |
| 18 | negative regulation of cell killing (GO:0031342) | 4.45589294 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.45589294 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.31448157 |
| 21 | negative regulation of viral genome replication (GO:0045071) | 4.30248331 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25749719 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.15916425 |
| 24 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.14244207 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.12185623 |
| 26 | granulocyte activation (GO:0036230) | 4.07802473 |
| 27 | response to interferon-alpha (GO:0035455) | 4.05356899 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.97998474 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97998474 |
| 30 | detection of bacterium (GO:0016045) | 3.96108054 |
| 31 | regulation of activation of Janus kinase activity (GO:0010533) | 3.93704228 |
| 32 | detection of other organism (GO:0098543) | 3.89864208 |
| 33 | defense response to protozoan (GO:0042832) | 3.89539799 |
| 34 | regulation of chemokine biosynthetic process (GO:0045073) | 3.83580325 |
| 35 | respiratory burst (GO:0045730) | 3.80916326 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.77899865 |
| 37 | * response to interferon-beta (GO:0035456) | 3.77391559 |
| 38 | neutrophil activation (GO:0042119) | 3.76107487 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.74341078 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.71496815 |
| 41 | positive regulation of interferon-beta production (GO:0032728) | 3.68085704 |
| 42 | positive regulation of type 2 immune response (GO:0002830) | 3.67955005 |
| 43 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.66855785 |
| 44 | eosinophil chemotaxis (GO:0048245) | 3.65657052 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64210558 |
| 46 | * cellular response to interferon-beta (GO:0035458) | 3.63226819 |
| 47 | B cell mediated immunity (GO:0019724) | 3.59816698 |
| 48 | cellular response to zinc ion (GO:0071294) | 3.59408135 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.56361770 |
| 50 | superoxide anion generation (GO:0042554) | 3.55700108 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.55014645 |
| 52 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.54328055 |
| 53 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.54266224 |
| 54 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.52543095 |
| 55 | natural killer cell mediated immunity (GO:0002228) | 3.52543095 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.52159962 |
| 57 | monocyte chemotaxis (GO:0002548) | 3.52027324 |
| 58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51333527 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.50067317 |
| 60 | positive regulation of interleukin-12 production (GO:0032735) | 3.49657776 |
| 61 | T cell migration (GO:0072678) | 3.42759905 |
| 62 | response to protozoan (GO:0001562) | 3.39232006 |
| 63 | response to host immune response (GO:0052572) | 3.38108014 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.38108014 |
| 65 | regulation of RIG-I signaling pathway (GO:0039535) | 3.36984177 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36585609 |
| 67 | positive regulation of heat generation (GO:0031652) | 3.36327933 |
| 68 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.35367843 |
| 69 | positive regulation of lymphocyte migration (GO:2000403) | 3.35316055 |
| 70 | reactive oxygen species biosynthetic process (GO:1903409) | 3.33534814 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33484234 |
| 72 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.33096291 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.32236763 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 3.32166216 |
| 75 | cellular response to virus (GO:0098586) | 3.31815729 |
| 76 | negative regulation of interleukin-17 production (GO:0032700) | 3.31537000 |
| 77 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.30194678 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 3.29532313 |
| 79 | cellular response to interferon-alpha (GO:0035457) | 3.27593302 |
| 80 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.27377803 |
| 81 | regulation of fever generation (GO:0031620) | 3.27351538 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 3.27318969 |
| 83 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.26764253 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26125933 |
| 85 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24229234 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.23596429 |
| 87 | eosinophil migration (GO:0072677) | 3.22055472 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19033786 |
| 89 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.18935344 |
| 90 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.17182013 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 3.16848565 |
| 92 | positive regulation of interleukin-17 production (GO:0032740) | 3.15318946 |
| 93 | regulation of mononuclear cell migration (GO:0071675) | 3.14701248 |
| 94 | B cell receptor signaling pathway (GO:0050853) | 3.13658344 |
| 95 | detection of external biotic stimulus (GO:0098581) | 3.13631523 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13471680 |
| 97 | regulation of interleukin-17 production (GO:0032660) | 3.13152186 |
| 98 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.11482443 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.10835172 |
| 100 | cytidine catabolic process (GO:0006216) | 3.09689061 |
| 101 | cytidine deamination (GO:0009972) | 3.09689061 |
| 102 | cytidine metabolic process (GO:0046087) | 3.09689061 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09160592 |
| 104 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08957659 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 3.07526393 |
| 106 | cellular response to interferon-gamma (GO:0071346) | 3.07447227 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04866554 |
| 108 | response to interferon-gamma (GO:0034341) | 3.03179637 |
| 109 | regulation of tolerance induction (GO:0002643) | 3.01986443 |
| 110 | leukocyte aggregation (GO:0070486) | 3.01118551 |
| 111 | regulation of T-helper cell differentiation (GO:0045622) | 3.01114616 |
| 112 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.00386660 |
| 113 | regulation of immunoglobulin secretion (GO:0051023) | 3.00330387 |
| 114 | leukocyte mediated cytotoxicity (GO:0001909) | 2.99983243 |
| 115 | mature B cell differentiation involved in immune response (GO:0002313) | 2.99495589 |
| 116 | NIK/NF-kappaB signaling (GO:0038061) | 2.99436506 |
| 117 | microglial cell activation (GO:0001774) | 2.98885226 |
| 118 | response to host (GO:0075136) | 2.98299477 |
| 119 | response to host defenses (GO:0052200) | 2.98299477 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98299477 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98049021 |
| 122 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.97116823 |
| 123 | positive thymic T cell selection (GO:0045059) | 2.95156307 |
| 124 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.94160182 |
| 125 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87305476 |
| 126 | cellular response to interleukin-15 (GO:0071350) | 2.86413598 |
| 127 | DNA deamination (GO:0045006) | 2.86260945 |
| 128 | negative T cell selection (GO:0043383) | 2.83880504 |
| 129 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.83634928 |
| 130 | positive regulation of B cell mediated immunity (GO:0002714) | 2.82959547 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.82959547 |
| 132 | regulation of interleukin-12 production (GO:0032655) | 2.82058246 |
| 133 | germinal center formation (GO:0002467) | 2.81937030 |
| 134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81306316 |
| 135 | negative thymic T cell selection (GO:0045060) | 2.81219188 |
| 136 | regulation of B cell differentiation (GO:0045577) | 2.79017480 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 2.78830740 |
| 138 | positive regulation of interleukin-10 production (GO:0032733) | 2.78365558 |
| 139 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77670858 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.76632314 |
| 141 | positive regulation of defense response to virus by host (GO:0002230) | 2.76607984 |
| 142 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.76049146 |
| 143 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.75715563 |
| 144 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75373530 |
| 145 | positive regulation of isotype switching (GO:0045830) | 2.73631476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.92024639 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.37393271 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.26668746 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.39371784 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.27502467 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.18438599 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.79665744 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63714675 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39166214 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26789203 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.26680211 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.13983337 |
| 13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.04663404 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86403755 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.77052881 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73321630 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.72955255 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62619930 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18172268 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17708812 |
| 21 | * MYC_22102868_ChIP-Seq_BL_Human | 1.97927395 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97691371 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88329301 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82039965 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81681318 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 1.78297238 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71922717 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68000107 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66666622 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65596254 |
| 31 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63582187 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.59495268 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55454333 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.53972407 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53873503 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52586478 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52404390 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44307059 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43377242 |
| 40 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.42286804 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.40325824 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39260876 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37351915 |
| 44 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36868840 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36069204 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35228365 |
| 47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35217133 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33200143 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32846813 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31173281 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30842312 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28648419 |
| 53 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27923215 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26726591 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23626338 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23308981 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22432015 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21930881 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21112335 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19326668 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18461510 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16922129 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15382667 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14181552 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12715908 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.11334967 |
| 67 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11241664 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09530017 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08387039 |
| 70 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07484279 |
| 71 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.06787702 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00843184 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00665685 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00554933 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99548590 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96481182 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96415502 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92338562 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92189530 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92020211 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91458815 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.91458482 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91314801 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 0.90100726 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88359659 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87329644 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86368203 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86073969 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.84358749 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83999534 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83385434 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82848875 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82737030 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82704017 |
| 95 | * MAF_26560356_Chip-Seq_TH2_Human | 0.82542774 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79004837 |
| 97 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78066359 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76293248 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76270292 |
| 100 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76120609 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.72834541 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72432206 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72131613 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.70469224 |
| 105 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69824933 |
| 106 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.66871085 |
| 107 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66843227 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65756257 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.65430740 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.65357847 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.65197199 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.61395342 |
| 113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.61134565 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.59697047 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58951398 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.57389474 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.56639538 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.55815627 |
| 119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.55815627 |
| 120 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55779671 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54829311 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.53226181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.07928864 |
| 2 | MP0009785_altered_susceptibility_to | 4.59689934 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.16167550 |
| 4 | MP0006082_CNS_inflammation | 3.87982124 |
| 5 | MP0003436_decreased_susceptibility_to | 3.86557569 |
| 6 | MP0003724_increased_susceptibility_to | 3.58670453 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.47180482 |
| 8 | MP0005025_abnormal_response_to | 3.36151979 |
| 9 | MP0002419_abnormal_innate_immunity | 3.19634361 |
| 10 | MP0000685_abnormal_immune_system | 3.19540865 |
| 11 | MP0005671_abnormal_response_to | 3.15618259 |
| 12 | MP0001790_abnormal_immune_system | 3.01676433 |
| 13 | MP0005387_immune_system_phenotype | 3.01676433 |
| 14 | MP0004510_myositis | 2.85726614 |
| 15 | MP0003303_peritoneal_inflammation | 2.81948520 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.78263946 |
| 17 | MP0002723_abnormal_immune_serum | 2.72088297 |
| 18 | MP0001800_abnormal_humoral_immune | 2.71960812 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.59060532 |
| 20 | MP0001819_abnormal_immune_cell | 2.40511167 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.36681692 |
| 22 | MP0009764_decreased_sensitivity_to | 2.19245102 |
| 23 | MP0002006_tumorigenesis | 2.11377999 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.09585098 |
| 25 | MP0004947_skin_inflammation | 2.08734678 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.95991275 |
| 27 | MP0002405_respiratory_system_inflammati | 1.94390351 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.94200730 |
| 29 | MP0008469_abnormal_protein_level | 1.82882330 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.81009558 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.77072013 |
| 32 | MP0000716_abnormal_immune_system | 1.75542330 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.73446846 |
| 34 | MP0002398_abnormal_bone_marrow | 1.69546567 |
| 35 | MP0003448_altered_tumor_morphology | 1.65543019 |
| 36 | MP0005310_abnormal_salivary_gland | 1.63438177 |
| 37 | * MP0001853_heart_inflammation | 1.56704547 |
| 38 | MP0000343_altered_response_to | 1.49281421 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.46974385 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.46974385 |
| 41 | MP0003075_altered_response_to | 1.46222247 |
| 42 | MP0000858_altered_metastatic_potential | 1.43570480 |
| 43 | MP0009278_abnormal_bone_marrow | 1.43240591 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.42694465 |
| 45 | MP0002429_abnormal_blood_cell | 1.41167418 |
| 46 | MP0003186_abnormal_redox_activity | 1.37683846 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.30745463 |
| 48 | * MP0000689_abnormal_spleen_morphology | 1.30016326 |
| 49 | MP0009840_abnormal_foam_cell | 1.27838445 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.25450144 |
| 51 | * MP0002722_abnormal_immune_system | 1.24387985 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.23265796 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.20327913 |
| 54 | MP0002254_reproductive_system_inflammat | 1.17582135 |
| 55 | MP0005451_abnormal_body_composition | 1.12141876 |
| 56 | MP0005166_decreased_susceptibility_to | 1.11748466 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.10209878 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.09246517 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.08738736 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.05093001 |
| 61 | MP0009763_increased_sensitivity_to | 1.03569718 |
| 62 | MP0005164_abnormal_response_to | 1.01378202 |
| 63 | MP0004381_abnormal_hair_follicle | 0.98090896 |
| 64 | MP0005390_skeleton_phenotype | 0.98039960 |
| 65 | MP0008004_abnormal_stomach_pH | 0.97669115 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 0.96946450 |
| 67 | MP0003828_pulmonary_edema | 0.94232466 |
| 68 | MP0002933_joint_inflammation | 0.90889404 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 0.88746144 |
| 70 | MP0003690_abnormal_glial_cell | 0.87822337 |
| 71 | MP0006054_spinal_hemorrhage | 0.87488609 |
| 72 | MP0002163_abnormal_gland_morphology | 0.78203250 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.77500925 |
| 74 | MP0003045_fibrosis | 0.76936685 |
| 75 | MP0000490_abnormal_crypts_of | 0.76673155 |
| 76 | MP0010307_abnormal_tumor_latency | 0.76052409 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.75031986 |
| 78 | MP0001851_eye_inflammation | 0.72833760 |
| 79 | MP0000249_abnormal_blood_vessel | 0.71802421 |
| 80 | MP0000604_amyloidosis | 0.71702440 |
| 81 | MP0008260_abnormal_autophagy | 0.71331857 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.67471485 |
| 83 | MP0003866_abnormal_defecation | 0.66753687 |
| 84 | MP0001542_abnormal_bone_strength | 0.65929317 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.64722606 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.64586402 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.64326127 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.64292034 |
| 89 | MP0001873_stomach_inflammation | 0.64098311 |
| 90 | MP0008874_decreased_physiological_sensi | 0.62712602 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62482795 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.60963321 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.59540513 |
| 94 | * MP0000703_abnormal_thymus_morphology | 0.58836960 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.58745575 |
| 96 | MP0004883_abnormal_blood_vessel | 0.57394461 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.57273148 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.56328278 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.55997110 |
| 100 | MP0000371_diluted_coat_color | 0.55057743 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.54727141 |
| 102 | MP0003795_abnormal_bone_structure | 0.53746182 |
| 103 | MP0008873_increased_physiological_sensi | 0.52921228 |
| 104 | MP0005535_abnormal_body_temperature | 0.52913403 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.52117666 |
| 106 | MP0003646_muscle_fatigue | 0.51793263 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.51682408 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.50063291 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.47789169 |
| 110 | MP0001663_abnormal_digestive_system | 0.47055961 |
| 111 | MP0005165_increased_susceptibility_to | 0.46690065 |
| 112 | MP0002132_abnormal_respiratory_system | 0.46183409 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.46134038 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.45257512 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.44864290 |
| 116 | MP0003091_abnormal_cell_migration | 0.44336561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.12960463 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.87548480 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.51662377 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.60186429 |
| 5 | Myositis (HP:0100614) | 5.34554839 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.26693753 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.25979038 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.03547231 |
| 9 | Orchitis (HP:0100796) | 4.98107869 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.86635414 |
| 11 | Optic neuritis (HP:0100653) | 4.86635414 |
| 12 | * Elevated erythrocyte sedimentation rate (HP:0003565) | 4.66326578 |
| 13 | Increased IgM level (HP:0003496) | 4.54671847 |
| 14 | Stomatitis (HP:0010280) | 4.34014660 |
| 15 | Recurrent skin infections (HP:0001581) | 4.26540313 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.98456818 |
| 17 | Interstitial pulmonary disease (HP:0006530) | 3.89706393 |
| 18 | * Vasculitis (HP:0002633) | 3.89531380 |
| 19 | Gingivitis (HP:0000230) | 3.85715887 |
| 20 | Obstructive lung disease (HP:0006536) | 3.78272403 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.78272403 |
| 22 | Chronic otitis media (HP:0000389) | 3.68741150 |
| 23 | Recurrent viral infections (HP:0004429) | 3.64783766 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.44403129 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38925202 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38925202 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 3.32476479 |
| 28 | Increased IgE level (HP:0003212) | 3.27514350 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.22509270 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.17753840 |
| 31 | * Basal ganglia calcification (HP:0002135) | 3.12531545 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.09406625 |
| 33 | Meningitis (HP:0001287) | 3.08013679 |
| 34 | Cellulitis (HP:0100658) | 3.05567329 |
| 35 | Pustule (HP:0200039) | 3.04358932 |
| 36 | Tetraparesis (HP:0002273) | 3.04080537 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.99491599 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 2.97986169 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.97276906 |
| 40 | Urticaria (HP:0001025) | 2.95188826 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.92753927 |
| 42 | Periodontitis (HP:0000704) | 2.91948366 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.91778350 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.91756366 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.75923762 |
| 46 | Axonal loss (HP:0003447) | 2.75447492 |
| 47 | Nasal polyposis (HP:0100582) | 2.74144749 |
| 48 | Recurrent lower respiratory tract infections (HP:0002783) | 2.73175088 |
| 49 | Hemoptysis (HP:0002105) | 2.73098848 |
| 50 | Leukocytosis (HP:0001974) | 2.72595889 |
| 51 | Prostate neoplasm (HP:0100787) | 2.72349719 |
| 52 | Thick nail (HP:0001805) | 2.71192773 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.71116595 |
| 54 | Arterial thrombosis (HP:0004420) | 2.70116671 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.67525933 |
| 56 | Loss of speech (HP:0002371) | 2.64766086 |
| 57 | * Purpura (HP:0000979) | 2.64617141 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.54048945 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.53428143 |
| 60 | * Systemic lupus erythematosus (HP:0002725) | 2.51593118 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45005382 |
| 62 | Increased serum ferritin (HP:0003281) | 2.44651860 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.43615401 |
| 64 | * Hepatosplenomegaly (HP:0001433) | 2.42341191 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41990001 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41990001 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41990001 |
| 68 | Restrictive lung disease (HP:0002091) | 2.41056192 |
| 69 | Gingival bleeding (HP:0000225) | 2.39945998 |
| 70 | Thrombocytosis (HP:0001894) | 2.39184510 |
| 71 | Skin rash (HP:0000988) | 2.38571705 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.36759066 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.36605038 |
| 74 | Joint swelling (HP:0001386) | 2.34793574 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.31381058 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.30993206 |
| 77 | Colitis (HP:0002583) | 2.29946486 |
| 78 | Osteomyelitis (HP:0002754) | 2.29257202 |
| 79 | Anorexia (HP:0002039) | 2.28393403 |
| 80 | Hypertensive crisis (HP:0100735) | 2.28029691 |
| 81 | Abnormality of T cells (HP:0002843) | 2.27740244 |
| 82 | Peritonitis (HP:0002586) | 2.27613210 |
| 83 | Pulmonary embolism (HP:0002204) | 2.23757433 |
| 84 | Lymphopenia (HP:0001888) | 2.22204309 |
| 85 | Chronic diarrhea (HP:0002028) | 2.21894798 |
| 86 | Eosinophilia (HP:0001880) | 2.21153192 |
| 87 | Disinhibition (HP:0000734) | 2.20657593 |
| 88 | Severe combined immunodeficiency (HP:0004430) | 2.19958346 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.18833312 |
| 90 | IgM deficiency (HP:0002850) | 2.16028973 |
| 91 | Glomerulopathy (HP:0100820) | 2.16003023 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.14810872 |
| 93 | Gangrene (HP:0100758) | 2.14000152 |
| 94 | Glomerulonephritis (HP:0000099) | 2.11400894 |
| 95 | Progressive neurologic deterioration (HP:0002344) | 2.10897232 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.09880431 |
| 97 | Chronic sinusitis (HP:0011109) | 2.09745014 |
| 98 | IgG deficiency (HP:0004315) | 2.09436262 |
| 99 | Amyloidosis (HP:0011034) | 2.09012221 |
| 100 | * Arthralgia (HP:0002829) | 2.08189511 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.08114730 |
| 102 | IgA deficiency (HP:0002720) | 2.06469828 |
| 103 | Acute hepatic failure (HP:0006554) | 2.06377493 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05467635 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05467635 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05467635 |
| 107 | Encephalitis (HP:0002383) | 2.04769144 |
| 108 | Inflammation of the large intestine (HP:0002037) | 2.04615801 |
| 109 | Vertebral compression fractures (HP:0002953) | 2.04060745 |
| 110 | Emphysema (HP:0002097) | 2.01631293 |
| 111 | Granulocytopenia (HP:0001913) | 1.98167984 |
| 112 | * Skin ulcer (HP:0200042) | 1.95496041 |
| 113 | Hematochezia (HP:0002573) | 1.94893920 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.93752652 |
| 115 | Abnormality of eosinophils (HP:0001879) | 1.93474915 |
| 116 | Sepsis (HP:0100806) | 1.93124032 |
| 117 | T lymphocytopenia (HP:0005403) | 1.92346597 |
| 118 | * Petechiae (HP:0000967) | 1.91838886 |
| 119 | Dysostosis multiplex (HP:0000943) | 1.91184122 |
| 120 | Epistaxis (HP:0000421) | 1.91045422 |
| 121 | * Abnormality of the pleura (HP:0002103) | 1.90100563 |
| 122 | Chest pain (HP:0100749) | 1.89904385 |
| 123 | Agnosia (HP:0010524) | 1.89887893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.54303226 |
| 2 | BLK | 4.24885204 |
| 3 | TBK1 | 4.15164015 |
| 4 | PBK | 3.44725438 |
| 5 | TYK2 | 3.39846162 |
| 6 | IRAK4 | 3.23944513 |
| 7 | RIPK4 | 3.18987733 |
| 8 | IKBKE | 3.15629501 |
| 9 | MAP4K1 | 2.93895582 |
| 10 | PIM2 | 2.92687738 |
| 11 | JAK3 | 2.87677462 |
| 12 | IKBKB | 2.72964935 |
| 13 | TXK | 2.57769011 |
| 14 | IRAK3 | 2.38470567 |
| 15 | KIT | 2.32585422 |
| 16 | TESK2 | 2.01055108 |
| 17 | ERN1 | 1.92433064 |
| 18 | JAK1 | 1.92083546 |
| 19 | MAP3K13 | 1.89243904 |
| 20 | NME2 | 1.81487883 |
| 21 | TNK2 | 1.74926242 |
| 22 | CHUK | 1.63312900 |
| 23 | SYK | 1.60709327 |
| 24 | PRPF4B | 1.54203895 |
| 25 | ZAP70 | 1.52950469 |
| 26 | BMPR2 | 1.46671362 |
| 27 | TAOK1 | 1.44593109 |
| 28 | RPS6KA4 | 1.41583681 |
| 29 | ARAF | 1.37520406 |
| 30 | BTK | 1.30985095 |
| 31 | CSK | 1.28250618 |
| 32 | SIK3 | 1.27024807 |
| 33 | TEC | 1.24753771 |
| 34 | ABL2 | 1.24246857 |
| 35 | BCKDK | 1.20965903 |
| 36 | MST4 | 1.20498922 |
| 37 | SMG1 | 1.18204635 |
| 38 | NEK9 | 1.18174422 |
| 39 | LYN | 1.18078241 |
| 40 | VRK2 | 1.14300101 |
| 41 | PIM1 | 1.13713372 |
| 42 | HCK | 1.12448270 |
| 43 | CSF1R | 1.11392414 |
| 44 | TLK1 | 1.10141847 |
| 45 | BMX | 1.10079729 |
| 46 | EIF2AK2 | 1.06515152 |
| 47 | LCK | 1.02621297 |
| 48 | FGFR4 | 1.02464321 |
| 49 | MATK | 1.02019622 |
| 50 | MAP3K12 | 0.96028272 |
| 51 | JAK2 | 0.92068395 |
| 52 | EPHB1 | 0.88415653 |
| 53 | FGR | 0.84840845 |
| 54 | TGFBR2 | 0.84746103 |
| 55 | HIPK2 | 0.83839713 |
| 56 | MAP3K5 | 0.80931868 |
| 57 | MARK3 | 0.80744702 |
| 58 | FES | 0.78945346 |
| 59 | MAP3K11 | 0.78407846 |
| 60 | PRKCD | 0.75414815 |
| 61 | EPHA3 | 0.72536754 |
| 62 | DAPK1 | 0.72521523 |
| 63 | IRAK1 | 0.71266299 |
| 64 | STK4 | 0.70656562 |
| 65 | TESK1 | 0.68442284 |
| 66 | TAOK3 | 0.67077917 |
| 67 | ADRBK2 | 0.65802259 |
| 68 | MAPK12 | 0.65046532 |
| 69 | KDR | 0.64549766 |
| 70 | FGFR3 | 0.62884762 |
| 71 | STK10 | 0.61735282 |
| 72 | MST1R | 0.60453727 |
| 73 | GRK7 | 0.59607500 |
| 74 | ERBB3 | 0.58440592 |
| 75 | ABL1 | 0.57843300 |
| 76 | YES1 | 0.56712630 |
| 77 | TRPM7 | 0.56604680 |
| 78 | VRK1 | 0.53189526 |
| 79 | PDK1 | 0.52886086 |
| 80 | LRRK2 | 0.52122079 |
| 81 | BMPR1B | 0.51585456 |
| 82 | PRKD2 | 0.51461792 |
| 83 | MAP2K6 | 0.50600968 |
| 84 | NLK | 0.48492561 |
| 85 | TIE1 | 0.48121920 |
| 86 | CDC42BPA | 0.48102833 |
| 87 | MAP2K3 | 0.46731529 |
| 88 | MAPK7 | 0.46282030 |
| 89 | IRAK2 | 0.45727400 |
| 90 | EGFR | 0.45181359 |
| 91 | MOS | 0.45007221 |
| 92 | MAPKAPK2 | 0.42828284 |
| 93 | MAPKAPK3 | 0.42547668 |
| 94 | FLT3 | 0.42194820 |
| 95 | PTK2B | 0.41653246 |
| 96 | PRKCQ | 0.40394426 |
| 97 | CLK1 | 0.39066093 |
| 98 | MAP3K1 | 0.38924561 |
| 99 | MAP3K8 | 0.38858402 |
| 100 | TGFBR1 | 0.38084557 |
| 101 | MUSK | 0.37392973 |
| 102 | PDPK1 | 0.37049034 |
| 103 | DDR2 | 0.36665634 |
| 104 | RPS6KA5 | 0.33792624 |
| 105 | SIK1 | 0.33414081 |
| 106 | CDK4 | 0.32936971 |
| 107 | DAPK3 | 0.32845646 |
| 108 | GRK5 | 0.32094099 |
| 109 | SCYL2 | 0.31456773 |
| 110 | DAPK2 | 0.31422392 |
| 111 | RPS6KA6 | 0.31232988 |
| 112 | RAF1 | 0.27910462 |
| 113 | ITK | 0.23086478 |
| 114 | PIK3CG | 0.23004732 |
| 115 | RPS6KA1 | 0.22888342 |
| 116 | SIK2 | 0.20440989 |
| 117 | MAPK4 | 0.19496336 |
| 118 | MAP3K3 | 0.18570219 |
| 119 | NUAK1 | 0.18371400 |
| 120 | GRK6 | 0.17116385 |
| 121 | MAPK11 | 0.15746446 |
| 122 | IGF1R | 0.14328456 |
| 123 | FYN | 0.13330805 |
| 124 | RPS6KC1 | 0.11023634 |
| 125 | RPS6KL1 | 0.11023634 |
| 126 | EIF2AK3 | 0.09831144 |
| 127 | TAOK2 | 0.09550976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.08278675 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.37214104 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.32130405 |
| 4 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.29940247 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.08086087 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71691879 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.68701844 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.67986670 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.54967026 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.50793158 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44360893 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.42644349 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.36910312 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.33584558 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.31141173 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28345203 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.26256822 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.21056337 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11276933 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 2.08155026 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.05901702 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 2.00570050 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.86954955 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.86582075 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.76752040 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.70067996 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65678361 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54629119 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54158818 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51948529 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48221684 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47680590 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41786805 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36553429 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31672895 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28391077 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.28162021 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.25191445 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.23016087 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20650984 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.17042380 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.06870758 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.00420092 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.99627312 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94396394 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91204497 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84720857 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.83010342 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78368019 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76943671 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.76844135 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76478710 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74514784 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66350820 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65776906 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63035294 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60292168 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59972454 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59484272 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55779528 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53033949 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50196238 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44182518 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43119679 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41603143 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41150072 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.39651317 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38726535 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.38036744 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34692887 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33591032 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33239511 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31467331 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30663142 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30489607 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29841095 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29726377 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29591816 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29121764 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25987302 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25378798 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25301035 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25092722 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24613965 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20867854 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.20416720 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.19697464 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.19482944 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18885042 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18244988 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.18033918 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16300538 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15998224 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14301484 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12554676 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11883694 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.10980156 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10568646 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10011848 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.07289354 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07005626 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.06749117 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.06492732 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05507185 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05066025 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04343099 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.04078281 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.03830795 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03129797 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.02470926 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.02262538 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01347056 |
| 113 | Homologous recombination_Homo sapiens_hsa03440 | 0.00194869 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.00069063 |
| 115 | Base excision repair_Homo sapiens_hsa03410 | -0.0112650 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | -0.0060012 |

